CN Patent

CN101970475A — 人类胰多肽(hpp)类似物及其对摄食行为的作用

Assigned to Ip2ipo Innovations Ltd · Expires 2011-02-09 · 15y expired

What this patent protects

含有一个或多个残基上的氨基酸取代而与天然人类胰多肽不同的人类胰多肽的类似物；和一种或多种所述化合物的应用，使用一种或多种所述化合物的方法，包含一种或多种所述化合物的的组合物；以及制备所述化合物的方法。

USPTO Abstract

含有一个或多个残基上的氨基酸取代而与天然人类胰多肽不同的人类胰多肽的类似物；和一种或多种所述化合物的应用，使用一种或多种所述化合物的方法，包含一种或多种所述化合物的的组合物；以及制备所述化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101970475A
Jurisdiction
CN
Classification
—
Expires
2011-02-09
Drug substance claim
No
Drug product claim
No
Assignee
Ip2ipo Innovations Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.